Acyclic N-(azacycloalkyl)bisindolylmaleimides: Isozyme selective inhibitors of PKCβ

Bioorganic and Medicinal Chemistry Letters

Volumn 13, Issue 11, 2003, Pages 1857-1859

  Faul, Margaret M ^a   Gillig, James R ^a   Jirousek, Michael R ^b   Ballas, Lawrence M ^c   Schotten, Theo ^a   Kahl, Astrid ^a   Mohr, Michael ^a  

^a ELI LILLY AND COMPANY   (United States)

^b PFIZER GLOBAL RESEARCH AND DEVELOPMENT   (United States)

^c Sphinx Pharmaceuticals   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ISOENZYME; PHOSPHOTRANSFERASE; PROTEIN KINASE C; PROTEIN KINASE C ALPHA; PROTEIN KINASE C BETA; PROTEIN KINASE C DELTA; PROTEIN KINASE C EPSILON; PROTEIN KINASE C ETA; PROTEIN KINASE C GAMMA; PROTEIN KINASE C LAMBDA; RUBOXISTAURIN; STAUROSPORINE; STAUROSPORINE DERIVATIVE; UNCLASSIFIED DRUG;

ARTICLE; COMPARATIVE STUDY; DRUG ACTIVITY; DRUG SCREENING; DRUG SELECTIVITY; DRUG STRUCTURE; DRUG SYNTHESIS; EVALUATION; IC 50; INHIBITION KINETICS; STRUCTURE ACTIVITY RELATION; STRUCTURE ANALYSIS;

EID: 0038394537     PISSN: 0960894X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0960-894X(03)00286-5     Document Type: Article

References (16)

1. Lester D.S., Epand R.M. Protein Kinase C; Current Concepts and Future Perspectives. 1992;Ellis Harwood, New York.
2. Carter C.A. Curr. Drug Targets. 1:2000;163.
3. Ishii H., Jirousek M.R., Koya D., Takagi C., Xia P., Clermont A., Bursell S.E., Kern T.S., Ballas L.M., Heath W.F., Stramm L.E., Feener E.P., King G.L. Science. 272:1996;728.
4. Hisayama T., Nakayama K., Saito N., Kihara Y., Nishizawa S., Obara K., Ishizuka T. Nippon Yakurigaku Zasshi. 119:2002;65.
5. Goekjian P.G., Jirousek M.R. Exp. Opin. Invest. Drugs. 10:2001;2117.
6. Van Gijn R., Zuidema X., Bult A., Beijnen J.H. J. Oncol. Pharm. Pract. 5:1999;166.
7. Gribble, G. W., Berthel, S. J. Stud. Nat. Prod. Chem. 1993, (Stereoselective Synthesis (Pt. H)), 365.
8. Jirousek M.R., Gillig J.R., Gonzalez C.M., Heath W.F., McDonald J.H.R., Neel D.A., Rito C.J., Singh U., Stramm L.E., Melikian-Badalian A., Baevsky M., Ballas L.M., Hall S.E., Winneroski L.L., Faul M.M. J. Med. Chem. 39:1996;2664.
9. Danis R.P., Bingaman D.P., Jirousek M.R., Yang Y. Invest. Ophthal. Vis. Sci. 39:1998;171.
10. Faul M.M., Winneroski L.L., Krumrich C.A., Sullivan K.A., Gillig J.R., Neel D.A., Rito C.J., Jirousek M.R. J. Org. Chem. 63:1998;1961.
11. Bit R.A., Crackett P.H., Harris W., Hill C.H. Tet. Lett. 34:1993;5623.
12. 2O.
13. 3 was added carefully, followed by DCM. The precipitate obtained was filtered, thoroughly rinsed with water and dried.
14. Faul, M. M.; Grutsch, J. L.; Kobierski, M. E.; Kopach, M. E.; Krumrich, C. A.; Staszak, M. A.; Sullivan, K. A.; Udodong, U.; Vicenzi, J. T. Tetrahedron 2003, submitted for publication.
15. Kennedy M.B., McGuinness T., Greengard P. J. Neurosci. 3:1983;818.
16. PKCs are ubiquitously expressed, although the levels of individual isoaymes vary considerable among different cells and tissues. PKCα is found in most cells and tissues. PKCβ is mainly expressed in immune function cells as well as some epithelial cells.